Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.…
Mirion: 3 Key Takeaways for Long-Term Investors
Mirion Technologies (NYSE: MIR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Industrial Machinery industry, part of the Industrials sector, and reports about 3,200 employees.
The shares were at 16.07 USD on 20 November 2026, down 32.6% over 52 weeks. Its 52-week range is 14.04 USD to 27.49 USD: the price is 41.5% below the high and 14.5% above the low.
At a market capitalisation of 4.04B USD, it trades at 146.1 times trailing earnings and 24.3 times forward earnings. The median trailing P/E of its 20 largest Specialty Industrial Machinery peers is 27.6, a premium of 429% for MIR.
Mirion Technologies reports return on equity of 1.5%, an operating margin of 7.5% and revenue up 24.5% year over year.
Its debt exceeds its cash by 826.40M USD, a debt-to-equity ratio of 0.66. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 11 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 23.18 USD is 44.3% above the current price. The next earnings report is expected on 9 February 2027.